Cytek BioSciences, Inc. (CTKB) Social Stream
CYTEK BIOSCIENCES INC (CTKB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CTKB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 2 | $27 | $27 | $27 | $6.99 | 286.27% |
| 2022-01-06 | 3 | $27 | $20 | $23.5 | $6.99 | 236.19% |
| 2022-02-25 | 3 | $20 | $18 | $19 | $6.99 | 171.82% |
| 2022-02-28 | 3 | $18 | $17 | $17.5 | $6.99 | 150.36% |
| 2022-05-12 | 3 | $17 | $11 | $14 | $6.99 | 100.29% |
| 2022-05-16 | 3 | $12 | $11 | $11.5 | $6.99 | 64.52% |
| 2022-07-19 | 4 | $15 | $11 | $12.666 | $6.99 | 81.2% |
| 2022-08-12 | 4 | $17 | $12 | $14.666 | $6.99 | 109.81% |
| 2022-11-10 | 3 | $17 | $15 | $16 | $6.99 | 128.9% |
| 2022-11-13 | 3 | $18 | $15 | $16.666 | $6.99 | 138.43% |
| 2022-11-14 | 3 | $17 | $15 | $16.333 | $6.99 | 133.66% |
| 2022-12-14 | 4 | $17 | $15 | $16.5 | $6.99 | 136.05% |
| 2023-03-02 | 4 | $17 | $14 | $15.5 | $6.99 | 121.75% |
| 2023-03-06 | 4 | $17 | $14 | $15 | $6.99 | 114.59% |
| 2023-04-11 | 4 | $17.001 | $14 | $15 | $6.99 | 114.59% |
| 2023-06-28 | 4 | $17.001 | $12 | $14.25 | $6.99 | 103.86% |
| 2023-08-15 | 5 | $17.001 | $12 | $14.25 | $6.99 | 103.86% |
| 2023-10-15 | 5 | $17.001 | $10 | $13 | $6.99 | 85.98% |
| 2023-10-24 | 5 | $17.001 | $8 | $11.75 | $6.99 | 68.1% |
| 2023-11-08 | 5 | $12 | $8 | $10.5 | $6.99 | 50.21% |
The Trend in the Analyst Price Target
Over the past 51 weeks, CTKB's average price target has gone down $6.17.
Over the past 47 weeks, CTKB's average upside potential has been 75.52%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-06 | 4 | 17.000 | 14 | 15.00 | 10.150 | 47.78% |
| 2023-05-10 | 4 | 17.001 | 12 | 14.25 | 8.865 | 60.74% |
| 2023-06-28 | 4 | 17.001 | 12 | 14.25 | 8.090 | 76.14% |
| 2023-08-13 | 5 | 17.001 | 12 | 14.25 | 9.390 | 51.76% |
| 2023-11-08 | 5 | 12.000 | 8 | 10.50 | 5.000 | 110% |
CTKB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 26 weeks, CTKB's average broker recommendation rating worsened by 0.3.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CTKB as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, CYTEK BIOSCIENCES INC's number of analysts covering the stock is greater than 269% of them.
- CYTEK BIOSCIENCES INC's average analyst price target is greater than 257.69% of Measuring and Control Equipment stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, CYTEK BIOSCIENCES INC's variance in analysts' estimates is lower than -304.39% of them.
- CTKB has a greater upside potential (average analyst target price relative to current price) than 1790.28% of Measuring and Control Equipment stocks.
In the Measuring and Control Equipment industry, NVMI, CAMT, and COHR are the three stocks most similar to CYTEK BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for CTKB? Use POWR Ratings for clearer insight into price direction.